US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Provident

18.63

+0.01000.05%

Post-market: 18.630.00000.00%16:20 EDT

Volume:717.00K

Turnover:13.34M

Market Cap:2.43B

PE:15.68

High:18.78

Open:18.71

Low:18.48

Close:18.62

Loading ...

Overview Company News Filings

Akora Resources delivers high-quality, low capex results from Bekisopa DSO with pre-feasibility study

Hot Chili unveils blockbuster PFS in booming copper-gold market

The Sydney Morning Herald

Hot Chili Limited Unveils Feasibility Study for Huasco Water Project

Press Release: Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Press Release: Tyra Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights

Japanese Drug Regulator Approves Genmab Cancer Drug For Patients With Advanced Cervical Cancer

3 Value Stocks Trading Below Estimated Worth For Savvy Investors

Simply Wall St.

TIVDAK® (tisotumab vedotin) Approved by Japan Ministry of Health, Labour and Welfare for the Treatment of Advanced or Recurrent Cervical Cancer that has Progressed on or after Chemotherapy

Press Release: CStone Pharmaceuticals Announces 2024 Annual Results and Recent Business Progress

Press Release: ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update

March 2025 Stocks That May Be Priced Below Estimated Value

Simply Wall St.

Press Release: Immatics Announces Full Year 2024 Financial Results and Business Update

Hot Chili Announces PFS & Maiden(1) Mineral Reserve(2) for the Costa Fuego Cu-Au Project

Hot Chili Unveils PFS and Ore Reserve for Costa Fuego Project

‘Strong basis’: Hot Chili celebrates on-time, robust PFS for Costa Fuego

The Market Herald

Hot Chili unveils blockbuster PFS in booming copper-gold market

The West Australian

Penny Stock Leap Therapeutics Unveils Positive Data From Experimental Combo Therapy For Colorectal Cancer

Press Release: Arverne Group Achieves All Its 2024 Targets and Confirms a Solid Outlook

Sonnet BioTherapeutics Successfully Completes First Safety Review of SON-1010 in Combination with Trabectedin in Certain Sarcomas

March 2025 Value Equities That Could Be Trading Below Estimated Worth

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PFS/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PFS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFS\",,,,,undefined,":{"symbol":"PFS","market":"US","secType":"STK","nameCN":"Provident","latestPrice":18.63,"timestamp":1752868800000,"preClose":18.62,"halted":0,"volume":717004,"hourTrading":{"tag":"盘后","latestPrice":18.63,"preClose":18.63,"latestTime":"16:20 EDT","volume":37374,"amount":696277.62,"timestamp":1752870000579},"delay":0,"floatShares":126185309,"shares":130659942,"eps":1.188092,"marketStatus":"Post-Mkt","change":0.01,"latestTime":"07-18 18:18:13 EDT","open":18.71,"high":18.78,"low":18.48,"amount":13341199.1577,"amplitude":0.016112,"askPrice":21.31,"askSize":100,"bidPrice":18.27,"bidSize":49,"shortable":3,"etf":0,"ttmEps":1.188092,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1752883200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1042693200000,"exchange":"NYSE","adjPreClose":18.62,"dividendRate":0.05153,"preHourTrading":{"tag":"盘前","latestPrice":18.62,"preClose":18.62,"latestTime":"08:38 EDT","volume":1,"amount":18.62,"timestamp":1752842292170},"postHourTrading":{"tag":"盘后","latestPrice":18.63,"preClose":18.63,"latestTime":"16:20 EDT","volume":37374,"amount":696277.62,"timestamp":1752870000579},"volumeRatio":0.963428,"impliedVol":0.0758,"impliedVolPercentile":0.16},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PFS\",,,,,undefined,":{"symbol":"PFS","floatShares":126185309,"roa":"0.77%","roe":"6.77%","lyrEps":1.053397,"volumeRatio":0.963428,"shares":130659942,"dividePrice":0.96,"high":18.78,"amplitude":0.016112,"preClose":18.62,"low":18.48,"week52Low":14.335,"pbRate":"0.92","psRate":"3.48","week52High":22.24,"institutionHeld":0.6776,"latestPrice":18.63,"committee":-0.342282,"eps":1.188092,"divideRate":0.05153,"volume":717004,"delay":0,"ttmEps":1.188092,"open":18.71,"prevYearClose":18.87,"prevWeekClose":18.54,"prevMonthClose":17.53,"prevQuarterClose":17.53,"fiveDayClose":18.54,"twentyDayClose":16.14,"sixtyDayClose":16.01,"earningDate":1753286400000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PFS\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2523793397","title":"Akora Resources delivers high-quality, low capex results from Bekisopa DSO with pre-feasibility study","url":"https://stock-news.laohu8.com/highlight/detail?id=2523793397","media":"Small Caps","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523793397?lang=en_us&edition=fundamental","pubTime":"2025-03-31 08:13","pubTimestamp":1743380004,"startTime":"0","endTime":"0","summary":"Akora Resources  has confirmed a low capital cost entry case of US$60.6 million and a pre-tax cash flow of US$310m over an initial six-year mine life with a pre-feasibility study  for its wholly owned Bekisopa iron ore project in Madagascar.Start-up costs will include US$6.8m for engineering, procurement, construction and management, with a 15% contingency and a capital payback of 1.8 years from first production.The pre-tax cash flow uses a long-term benchmark iron ore price of US$100 per tonne to deliver a pre-tax net present value of US$147m and an 86% internal rate of return from the initial capital investment.Akora has based the PFS on a 2 million tonnes per annum direct shipping ore  operation to output blended grade lump and fines products for use by global blast furnace steelmakers, generating revenues of approximately US$789m.“Our team has worked hard to deliver this PFS on time and the expectation is that potential strategic investors will re-engage with us,” he said.“This PFS","market":"hk","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/03/Akora-Resources-ASX-AKO-Bekisopa-iron-ore-PFS.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/03/Akora-Resources-ASX-AKO-Bekisopa-iron-ore-PFS.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/akora-resources-high-quality-low-capex-bekisopa-dso-pre-feasibility-study/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["BK4195","PFS","BK7129","AKO.AU","BK4211"],"gpt_icon":0},{"id":"2523998703","title":"Hot Chili unveils blockbuster PFS in booming copper-gold market","url":"https://stock-news.laohu8.com/highlight/detail?id=2523998703","media":"The Sydney Morning Herald","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523998703?lang=en_us&edition=fundamental","pubTime":"2025-03-31 07:59","pubTimestamp":1743379140,"startTime":"0","endTime":"0","summary":"Hot Chili has dropped a bombshell prefeasibility study for its Costa Fuego copper-gold project in Chile, cementing its place among the world’s top copper developments with a 20-year mine life, top-tie","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.smh.com.au/business/companies/hot-chili-unveils-blockbuster-pfs-in-booming-copper-gold-market-20250331-p5lnt0.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"smh_stock","symbols":["DFS","BK4195","NPV","LU1861220207.SGD","LU2360107671.USD","PFS","LU1861217088.USD","BK4585","LU1791807156.HKD","LU0106831901.USD","LU1668664300.SGD","BK4166","BK4211","BK4588"],"gpt_icon":0},{"id":"2523198087","title":"Hot Chili Limited Unveils Feasibility Study for Huasco Water Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2523198087","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523198087?lang=en_us&edition=fundamental","pubTime":"2025-03-31 07:07","pubTimestamp":1743376047,"startTime":"0","endTime":"0","summary":"An announcement from Hot Chili Limited ( ($AU:HCH) ) is now available. Hot Chili Limited has announced a preliminary feasibility study (PFS) for it...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hot-chili-limited-unveils-feasibility-study-for-huasco-water-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hot-chili-limited-unveils-feasibility-study-for-huasco-water-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4195","PFS","BK4211"],"gpt_icon":0},{"id":"2523434680","title":"Press Release: Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2523434680","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523434680?lang=en_us&edition=fundamental","pubTime":"2025-03-29 04:10","pubTimestamp":1743192600,"startTime":"0","endTime":"0","summary":"Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update. -- Positive Preliminary Phase 1b/2 Data of Olvi-Vec in Advanced Small-Cell Lung Cancer --. -- Matt Pulisic joined the company as its new Chief Financial Officer --. -- Closing of $10.5 Million Underwritten Offering of Common Stock --. -- $30.9 million in cash, cash equivalents and short-term investments --. WESTLAKE VILLAGE, Calif., March 28, 2025  -- Genelux Corporation , a late clinical-stage immuno-oncology company, reported fourth quarter and full year 2024 financial results and business updates.\"Our progress in the fourth quarter of 2024 and into 2025 marks a pivotal period for patients, our company, and our investors,\" said Thomas Zindrick, President, CEO and Chairman of Genelux. \"We are pleased with the continued progress and promise of our clinical development program. The strengthening of our management team, with the addition of Matt, and of our balance sheet, with ou","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4195","BK4555","BK4588","TM","BK4099","BK4139","PFS","BK4097","GNLX","BK4585","OS","BK4604","03160","BK4211"],"gpt_icon":0},{"id":"2522539232","title":"Press Release: Tyra Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2522539232","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522539232?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:05","pubTimestamp":1743105900,"startTime":"0","endTime":"0","summary":"- Three INDs cleared by US FDA for TYRA's proprietary precision small molecules -. - TYRA-300 to be evaluated in three Phase 2 studies: SURF302 for Intermediate Risk Non-Muscle Invasive Bladder Cancer , BEACH301 for pediatric achondroplasia  and SURF301 for metastatic urothelial cancer  -. - Cash, cash equivalents, and marketable securities of $341.4 million at YE 2024; runway through at least 2027 -. \"2024 was a momentous year for TYRA and the patient communities we serve, highlighted by the positive interim results from our SURF301 study, which demonstrated a combination of high anti-tumor activity with favorable tolerability results in very sick, heavily pre-treated cancer patients. Importantly, the oncology doses tested in SURF301 are significantly higher than those to be tested in BEACH301, giving us confidence as we advance TYRA-300 in ACH,\" said Todd Harris, CEO of TYRA. \"Our conviction in TYRA-300 has never been stronger and we are working diligently to advance this potential b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CR","BK4503","BK4153","BK4195","BK4563","ACH","BK4139","BK4211","BK4006","BK4166","BK4213","BK4161","HCC","QD","TYRA","PFS","PR"],"gpt_icon":0},{"id":"2522533947","title":"Japanese Drug Regulator Approves Genmab Cancer Drug For Patients With Advanced Cervical Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2522533947","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522533947?lang=en_us&edition=fundamental","pubTime":"2025-03-28 02:27","pubTimestamp":1743100046,"startTime":"0","endTime":"0","summary":"The Japanese Ministry of Health, Labour and Welfare on Thursday approved Genmab A/S’ Tivdak  for advanced or recurrent cervical cancer that has progressed on or after cancer chemotherapy.Tivdak is the first and only antibody-drug conjugate  to be approved for cervical cancer in Japan.The approval is based on data from the Phase 3 innovaTV 301 clinical trial that evaluated the efficacy and safety of TIVDAK compared to chemotherapy in patients with advanced or recurrent cervical cancer who were previously treated with chemotherapy.Also Read: AbbVie/Genmab’s Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway. The trial included 502 patients, 101 of which were Japanese.Median OS was 11.5 months among patients treated with Tivdak compared to 9.5 months for patients who received chemotherapy. Secondary endpoints of progression-free survival  and confirmed objective response rate  were also met.This article Japanese Drug Regulator Approves Genmab","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/japanese-drug-regulator-approves-genmab-182726829.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0170899867.USD","OS","ADC","LU1066053197.SGD","IE0031619046.USD","BK4568","BK4599","GMAB","LU0289739699.SGD","LU0122379950.USD","IE00BLSP4239.USD","BK4588","LU0058720904.USD","IE00B19Z3B42.SGD","AEIS","LU1883839398.USD","BK4585","BK4139","IE00BBT3K403.USD","LU1057294990.SGD","SG9999001176.SGD","BK4550","BK4157","LU0306807586.USD","LU0321505439.SGD","BK4592","SG9999001176.USD","LU0234572021.USD","LU0985481810.HKD","ORR","IE000M9KFDE8.USD","BK4534","LU1066051498.USD","LU0225284248.USD","LU0456855351.SGD","BK4195","IE00B66KJ199.SGD","BK4533","IE00B19Z4B17.USD","IE0002270589.USD","IE00BLSP4452.SGD","PFS","BK4211","IE00B19Z3581.USD","LU0321505868.SGD","SG9999013999.USD","LU1894683264.USD","IE00B7SZL793.SGD","BK4007"],"gpt_icon":1},{"id":"2522457582","title":"3 Value Stocks Trading Below Estimated Worth For Savvy Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2522457582","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522457582?lang=en_us&edition=fundamental","pubTime":"2025-03-28 01:08","pubTimestamp":1743095290,"startTime":"0","endTime":"0","summary":"As the U.S. stock market navigates the complexities of tariff news and economic data, investors are closely watching for signs of stability amid fluctuating indices. In this environment, identifying stocks trading below their estimated worth can be a strategic move, offering potential value opportunities in a market marked by uncertainty.Top 10 Undervalued Stocks Based On Cash Flows In The United States. Overview: Banc of California, Inc. is a bank holding company for Banc of California, offering a range of banking products and services, with a market cap of approximately $2.45 billion.Overview: Bowhead Specialty Holdings Inc. operates in the United States, offering commercial specialty property and casualty insurance products, with a market cap of approximately $1.34 billion.Bowhead Specialty Holdings is trading at US$40.36, below its estimated fair value of US$48.13, suggesting potential undervaluation based on cash flows. The company's earnings grew 52.7% last year and are projected","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-value-stocks-trading-below-170810860.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MC","LU2242652126.USD","BANC","PSTG","LU2092937221.SGD","LU1430597077.USD","BK4023","LU1863844749.USD","LU2360108059.USD","LU1861220033.SGD","LU0823421333.USD","LU0823421416.USD","KBR","LU2362541513.USD","SGXZ23171101.USD","LU1815336091.USD","BK4127","LU0385154629.USD","LU2298321311.HKD","BK4170","LU1803068623.USD","ISBC","BOW","SG9999004303.SGD","LU1559883803.SGD","LU2362541273.HKD","WK","LU1892829315.USD","LU2360106947.USD","LU2242646821.SGD","LU0048578792.EUR","LU0566484027.USD","LU0612318971.USD","BK4136","SW","LU0550127509.SGD","BK4585","LU0471298777.SGD","LU0823434583.USD","LU0612318385.USD","LU1920063259.USD","BK4107","LU0471298694.HKD","LU1878469433.USD","LU2362540622.SGD","PFS","LU0053671581.USD","BK4123","LU0997587240.USD","LU2360107168.USD"],"gpt_icon":0},{"id":"2522305374","title":"TIVDAK® (tisotumab vedotin) Approved by Japan Ministry of Health, Labour and Welfare for the Treatment of Advanced or Recurrent Cervical Cancer that has Progressed on or after Chemotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2522305374","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522305374?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:00","pubTimestamp":1743076800,"startTime":"0","endTime":"0","summary":"TIVDAK is the first and only antibody-drug conjugate  approved for patients with advanced or recurrent cervical cancer in Japan. Approval is based on results from the global Phase 3 innovaTV 301 trial, in which TIVDAK demonstrated superior overall survival compared to chemotherapy. Rising cervical cancer incidence and mortality rates in Japan signify need for new treatment options. COPENHAGEN, Denmark, March 27, 2025----Genmab A/S  today announced that the Japan Ministry of Health, Labour and Welfare has approved TIVDAK  for the treatment of advanced or recurrent cervical cancer that has progressed on or after cancer chemotherapy. TIVDAK is the first and only ADC to be approved for people living with cervical cancer in Japan.In recent years, cervical cancer incidence and mortality rates have increased in Japan, particularly among women under age 50.i,ii,iii Moreover, patients with recurrent or metastatic cervical cancer whose disease has progressed after first-line therapy have limited","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tivdak-tisotumab-vedotin-approved-japan-120000054.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0170899867.USD","OS","ADC","LU1066053197.SGD","IE0031619046.USD","BK4568","BK4599","GMAB","LU0289739699.SGD","SG9999002224.SGD","SGXZ57979304.SGD","LU1894683348.USD","LU0122379950.USD","BK4107","IE00BLSP4239.USD","LU0058720904.USD","AEIS","LU1883839398.USD","BK4585","BK4139","LU1057294990.SGD","SG9999001176.SGD","BK4550","BK4157","LU0306807586.USD","SG9999002232.USD","LU0321505439.SGD","BK4592","ORR","BK4097","IE000M9KFDE8.USD","LU0868494617.USD","LU1066051498.USD","LU0053666078.USD","LU0225284248.USD","LU0456855351.SGD","PN","SG9999011175.SGD","SG9999003800.SGD","BK4533","IE00B19Z4B17.USD","IE0002270589.USD","PFS","IE00B19Z3581.USD","LU0321505868.SGD","BK4080","L","SG9999013999.USD","BK4007"],"gpt_icon":1},{"id":"2522374205","title":"Press Release: CStone Pharmaceuticals Announces 2024 Annual Results and Recent Business Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2522374205","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522374205?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:55","pubTimestamp":1743076500,"startTime":"0","endTime":"0","summary":"-      Total Revenue: RMB 407.2 million, including RMB 232.1 million in licensing and royalty income.-          EU & UK: Approved for first-line treatment of stage IV non-small cell lung cancer ; stage III NSCLC new indication application submitted to EMA.-     Global Partnerships: Three strategic partnerships across 40+ countries, to accelerate global commercialization.-      Localized Production: Approved for localized manufacturing in China, enhancing cost efficiency.-      Commercial Collaboration: Partnered with Hengrui to expand market access in China.-      Leading Position: Top 2 globally in clinical development for ROR1-targeted ADCs.-      Preclinical Differentiation: Superior tumor suppression vs. benchmarked competitors; potential first-in-class/best-in-class IO backbone therapy.-      More than 9 Differentiated Candidates: Focus on first-in-class/best-in-class assets, including multispecific antibodies and ADCs, with global rights and broad therapeutic potential.SUZHOU, Ch","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4541","ADC","LU2294711713.HKD","BK4213","BK4570","BK4080","BK4182","LU2249611893.SGD","HL","LU0444971666.USD","LU0823414551.USD","LU2065732104.USD","BK4022","BK4124","LU0823414478.USD","LU2463526074.USD","ORR","BK4195","SITC","R","LU1642822529.SGD","BK4097","PFS","BK4109","LU1815336760.USD","BK4211","PRGS","SOC","BE","02616","BK4588","BK4232","LU0345780521.USD","BK4585","LU0476273544.USD","ASH","LU2506951792.HKD","BK1161","BK4231","OS","CPS","CEE","CDE","BK4210","LU0444973449.USD","LU0957808578.USD","BK4017","LU2357125470.USD","BK1574"],"gpt_icon":0},{"id":"2522379277","title":"Press Release: ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2522379277","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522379277?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:30","pubTimestamp":1743075000,"startTime":"0","endTime":"0","summary":"ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update. Initial data from LOTIS-7 Phase 1b trial of ZYNLONTA plus glofitamab demonstrated clinically meaningful benefit with 94% best ORR and 72% CR rate; data update expected in second quarter 2025. Completed enrollment in LOTIS-5 Phase 3 confirmatory trial of ZYNLONTA plus rituximab in patients with 2L+ DLBCL; data update anticipated in late 2025 once PFS events reached. $250.9M in cash as of December 31, 2024, provides runway expected to fund operations into the second half of 2026. LAUSANNE, Switzerland, March 27, 2025 /PRNewswire/ -- ADC Therapeutics SA , a commercial-stage global leader and pioneer in the field of antibody drug conjugates , today reported financial results for the fourth quarter and full year ended December 31, 2024, and provided recent operational updates.Fourth Quarter 2024 Operational Updates and Upcoming Milestones. and the complete response rate  was 72%. Th","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADCT","BK4604","BK4109","PFS","BK4022","BK4232","BK4094","ORR","BK4585","BK4231","R","BK4195","LENZ","BK4555","BK4211","03160","TM","FL","BK4588","ASH","BK4080","BK4099","LU2463526074.USD","ADC","PBD","BK4505"],"gpt_icon":0},{"id":"2522350379","title":"March 2025 Stocks That May Be Priced Below Estimated Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2522350379","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522350379?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:07","pubTimestamp":1743073668,"startTime":"0","endTime":"0","summary":"As the U.S. stock market faces turbulence due to impending auto tariffs and a tech sector selloff, investors are increasingly vigilant about identifying opportunities amid uncertainty. In this climate, undervalued stocks—those priced below their estimated intrinsic value—can offer potential for growth as they may be overlooked by the broader market sentiment.Top 10 Undervalued Stocks Based On Cash Flows In The United States. Alkami Technology is trading at US$27.48, below its estimated fair value of US$36.02, suggesting it may be undervalued based on cash flows. Recent partnerships with Greenlight and American Eagle Financial Credit Union enhance its digital banking platform offerings, potentially boosting revenue growth forecasted at 20% annually—significantly above the market average. Despite recent insider selling, Alkami's strategic collaborations and expected profitability within three years highlight its potential for investors focused on cash flow valuation.nCino is currently tr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/march-2025-stocks-may-priced-110748246.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1861215975.USD","LU2380233275.USD","LU2092937221.SGD","LU1548497426.USD","SGXZ81514606.USD","WK","LU0471298777.SGD","LU0354030438.USD","LU1720051108.HKD","LU2360107168.USD","LU0823421416.USD","LU1803068623.USD","SW","BK4209","BK4195","KBR","LU2108987350.USD","LU2360108059.USD","NCNO","LU0471298694.HKD","CMG","LU0566484027.USD","LU2362541273.HKD","LU1863844665.USD","LU0963586101.USD","LU2065169927.USD","ALKT","LU0612318385.USD","LU2362540622.SGD","LU1863844749.USD","LU0823421333.USD","LU0823434740.USD","LU1920062954.HKD","LU0612318971.USD","LU2360106947.USD","LU0654597011.USD","LU2242646821.SGD","LU1119994140.HKD","LU0320765059.SGD","LU0550127509.SGD","LU2041044095.USD","LU2290526834.HKD","LU1892829315.USD","PFS","LU0048578792.EUR","BK4588","LU0823434583.USD","LU0385154629.USD","PSTG","LU0354030511.USD"],"gpt_icon":0},{"id":"2522375178","title":"Press Release: Immatics Announces Full Year 2024 Financial Results and Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2522375178","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522375178?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:00","pubTimestamp":1743073200,"startTime":"0","endTime":"0","summary":"-- Randomized-controlled Phase 3 trial, SUPRAME, to evaluate ACTengine. IMA203 TCR-T  in advanced melanoma patients; first patient. -- ACTengine IMA203 TCR-T : Phase 1b IMA203 data published in. October 2024 demonstrated a confirmed ORR of 54%, 12.1 months mDOR, 6. months mPFS and OS not reached at a mFU time of 8.6 months in advanced. melanoma patients; next data update on Phase 1b trial with extended. published in November 2024 showed enhanced pharmacology and potency,planned; next data update including ovarian cancer data planned in 2025. \"2025 will be marked by milestones across our TCR-T and TCR Bispecifics clinical portfolio, including advancing two of our main objectives for this year: firstly, reporting data on solid cancer types beyond melanoma, such as ovarian cancer, head and neck cancer and others and secondly, demonstrating that our next-generation, half-life extended TCR Bispecifics can deliver meaningful response rates in advanced solid cancer patients,\" said Harpreet Si","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","IMTX","ORR","BK4139","BK4022","R","BK4195","BK4211","PFS"],"gpt_icon":0},{"id":"2522532272","title":"Hot Chili Announces PFS & Maiden(1) Mineral Reserve(2) for the Costa Fuego Cu-Au Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2522532272","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522532272?lang=en_us&edition=fundamental","pubTime":"2025-03-27 18:00","pubTimestamp":1743069600,"startTime":"0","endTime":"0","summary":"Top Quartile Copper Production Scale3, Lowest Quartile Capital Intensity Located on the Coastal Range in Chile. PERTH, Australia, March 27, 2025 /PRNewswire/ -Hot Chili Limited     is pleased to announce the results of a Pre-Feasibility Study , prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects  of the Canadian Securities Administrators, for its Costa Fuego copper-gold project . All monetary amounts are expressed in United States dollars unless otherwise indicated.Average Annual Production Increased 116 ktpa Average CuEq4Production Rate: Including 95 kt Cu and 48 koz Au during primary production . Competitive Cost Position: Life of mine  average C1 Cash Cost5of US$ 1.38/lb and All-in-Sustaining Cost of US$1.85/lb . Increase in Total Copper and Gold Production: 1.5 Mt Cu  and 780 koz Au produced over the LOM. Robust Financial Profile: Total LOM free cash flow of approximately US$3.86 Billion . Strong Economics and Leverage to Rising Cop","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance_au","url":"https://finance.yahoo.com/news/hot-chili-announces-pfs-maiden-100000256.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/hot-chili-announces-pfs-maiden-100000256.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7116","EIA","LOM.AU","BK4588","MHLD","BK4585","PFS","BK4195","BK4015","BK4019","BK4168","PC","CP","CMP.AU","CMP","BK7007","MRE.AU","BK4016","IRR","HHLKF","HCH.AU","BK4209","BK7110","LU1261432733.SGD","BK4211"],"gpt_icon":0},{"id":"2522346748","title":"Hot Chili Unveils PFS and Ore Reserve for Costa Fuego Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2522346748","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522346748?lang=en_us&edition=fundamental","pubTime":"2025-03-27 16:08","pubTimestamp":1743062885,"startTime":"0","endTime":"0","summary":"Hot Chili Limited ( ($AU:HCH) ) has shared an update. Hot Chili Limited has announced the Pre-Feasibility Study (PFS) and maiden ore reserve for it...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/hot-chili-unveils-pfs-and-ore-reserve-for-costa-fuego-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/hot-chili-unveils-pfs-and-ore-reserve-for-costa-fuego-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","BK4195","PFS"],"gpt_icon":0},{"id":"2522080366","title":"‘Strong basis’: Hot Chili celebrates on-time, robust PFS for Costa Fuego","url":"https://stock-news.laohu8.com/highlight/detail?id=2522080366","media":"The Market Herald","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522080366?lang=en_us&edition=fundamental","pubTime":"2025-03-27 08:38","pubTimestamp":1743035880,"startTime":"0","endTime":"0","summary":"Hot Chili  has today published a positive prefeasibility study and maiden ore reserve for its Costa Fuego copper-gold project in Chile, with the former showing robust production metrics over the expected 20-year mine life, with increased yield from both metals during that time.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.According to the PFS, Costa Fuega’s mine life will now be increased to 20 years, and average annual production has also jumped to 116,000 tonnes per annum  of copper equivalent, including 95,000 tonnes of copper and 48,000 ounces  of gold during the primary production period of 14 years.Over the life of Hot Chili’s mine, copper and gold production is being tipped to increase to 1.5 Mt Cu  and 780,000 oz Au).The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own rese","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/strong-basis-hot-chili-celebrates-on-time-robust-pfs-for-costa-fuego-2025-03-27/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK4211","BK4195","BK7110","HCH.AU","PFS"],"gpt_icon":0},{"id":"2522805317","title":"Hot Chili unveils blockbuster PFS in booming copper-gold market","url":"https://stock-news.laohu8.com/highlight/detail?id=2522805317","media":"The West Australian","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522805317?lang=en_us&edition=fundamental","pubTime":"2025-03-27 06:47","pubTimestamp":1743029261,"startTime":"0","endTime":"0","summary":"Hot Chili has dropped a bombshell PFS for its Costa Fuego copper-gold project in Chile, tabling a mammoth NPV and top-tier production profile in a surging copper-gold metals market.","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-18179519/343643156804c0cada2f5a500e9970bd1d879205.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-18179519/343643156804c0cada2f5a500e9970bd1d879205.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/bulls-n-bears/hot-chili-unveils-blockbuster-pfs-in-booming-copper-gold-market-c-18179519","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/bulls-n-bears/hot-chili-unveils-blockbuster-pfs-in-booming-copper-gold-market-c-18179519","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["LU1668664300.SGD","PFS","LU1861220207.SGD","DFS","LU0106831901.USD","LU1791807156.HKD","NPV","BK4585","BK4166","BK4211","LU2360107671.USD","LU1861217088.USD","BK4195","BK4588"],"gpt_icon":0},{"id":"2522455332","title":"Penny Stock Leap Therapeutics Unveils Positive Data From Experimental Combo Therapy For Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2522455332","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522455332?lang=en_us&edition=fundamental","pubTime":"2025-03-27 01:29","pubTimestamp":1743010151,"startTime":"0","endTime":"0","summary":"Leap Therapeutics, Inc. presented updated preliminary data on Wednesday from Part B of the DeFianCe Phase 2 trial of sirexatamab  in combination with bevacizumab and chemotherapy  compared to bevacizumab and chemotherapy .The trial enrolled patients with advanced microsatellite stable  colorectal cancer  who have received one prior systemic therapy for advanced disease.The updated analysis shared on Wednesday includes the overall response rate , an additional two months of patient follow-up for progression-free survival , and initial overall survival  data.As ofMarch 12, 2025, 34 patients remain on the study drug in the sirexatamab Experimental Arm compared to 24 patients in the Control Arm.In patients with highDKK1levels, the sirexatamab Experimental Arm has a statistically significant 32% higher ORR, 3.5 months longer PFS, and OS compared to the Control Arm:. In patients who had not received prior anti-VEGF therapy, the sirexatamab Experimental Arm has a statistically significant 22%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/penny-stock-leap-therapeutics-unveils-172911695.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PFS","MSS","IE00BMPRXN33.USD","BK4211","BK4585","BK4543","LU0348723411.USD","OS","BK4195","BK4141","BK4213","LU0266512127.USD","BK4563","IE00BMPRXQ63.HKD","LU0456854461.SGD","CRC","IE00BMPRXR70.SGD","LENZ","LPTX","BK4097","ORR","BK4139","BK4588","BK4505","ONC","BK4113","BK4609"],"gpt_icon":1},{"id":"2522806363","title":"Press Release: Arverne Group Achieves All Its 2024 Targets and Confirms a Solid Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2522806363","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522806363?lang=en_us&edition=fundamental","pubTime":"2025-03-27 00:45","pubTimestamp":1743007500,"startTime":"0","endTime":"0","summary":"-- +45% growth in gross business volume1, compared with 2023, reaching. -- Successful deployment of the EUR51.9m investment programme, in line with. -- Positive results of the pre-feasibility study  for Lithium de. -- New drilling permit application submitted, reinforcing the development. -- Continued strong growth in gross business volume, expected between EUR25m. and EUR30m, i.e. growth of +45% to 75% compared with 2024.-- Deployment of an investment programme of around EUR50m to support this. -- Launch of the pre-industrial phase of the geothermal heat and lithium. project in Alsace, for a period of 12 to 18 months, including in. particular the definitive feasibility study  and the operations of. -- Signing of contracts for the first geothermal heat production in 2026.Arverne Group  , a French industrial player harnessing renewable subsurface resources to accelerate the energy transition, announces its 2024 annual results.A dedicated presentation meeting for institutional investors ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4166","BK4195","LU1861220207.SGD","PFS","LU1791807156.HKD","BK4211","BK4585","LU2360107671.USD","LU1861217088.USD","DFS","LC","LU1668664300.SGD","LU0106831901.USD"],"gpt_icon":0},{"id":"2522234805","title":"Sonnet BioTherapeutics Successfully Completes First Safety Review of SON-1010 in Combination with Trabectedin in Certain Sarcomas","url":"https://stock-news.laohu8.com/highlight/detail?id=2522234805","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522234805?lang=en_us&edition=fundamental","pubTime":"2025-03-26 21:05","pubTimestamp":1742994300,"startTime":"0","endTime":"0","summary":"SON-1010 is being studied as a combination therapy with trabectedin (Yondelis), the first FDA-approved treatment for two types of advanced soft tissue sarcoma after failure of standard chemotherapy, d","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/26/3049745/0/en/Sonnet-BioTherapeutics-Successfully-Completes-First-Safety-Review-of-SON-1010-in-Combination-with-Trabectedin-in-Certain-Sarcomas.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFS","PK","LU0359202008.SGD","IE00BYTNYN87.SGD","LU1023057109.AUD","BK4533","LU0359201612.USD","BK4080","BK4108","BK4531","BK4526","BK4585","MTD","LU0347712357.USD","BK4509","PD","BK4231","BK4181","SONN","BK4139","BK4136","BK4195","BK4023","IE00BYQQ9H92.USD","LU2413666426.HKD","LU2413666699.HKD","BK4552","SG9999011746.SGD","IE00BFXG0V08.USD","SON","LU1093756168.USD","LU1721428933.USD","BK4588","BK4211","BK4563","BK4548","BK4007","BK4213","BK4571","01698","BK4121","BK4567","IE00B12V2V27.USD","BK4218","PR","IE00BYQNZ168.SGD","LU2039709279.SGD","SRC","PROC"],"gpt_icon":1},{"id":"2522755938","title":"March 2025 Value Equities That Could Be Trading Below Estimated Worth","url":"https://stock-news.laohu8.com/highlight/detail?id=2522755938","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522755938?lang=en_us&edition=fundamental","pubTime":"2025-03-26 19:07","pubTimestamp":1742987277,"startTime":"0","endTime":"0","summary":"As of March 2025, U.S. stock markets have been experiencing a modest recovery, with major indices like the S&P 500 and Nasdaq Composite showing slight gains after rebounding from a recent selloff driven by tariff concerns and economic uncertainty. In this environment, identifying undervalued stocks can be particularly appealing to investors looking for opportunities that may offer potential growth as the market stabilizes.Top 10 Undervalued Stocks Based On Cash Flows In The United States. Analog Devices is trading at US$213.58, below its estimated fair value of US$260.96, suggesting it may be undervalued based on cash flows. Despite a decrease in profit margins from 24.4% to 16.7%, the company's earnings are forecast to grow significantly at 24.8% annually, outpacing the broader U.S market growth rate of 14%. Recent product innovations and strategic partnerships enhance its competitive edge, though significant insider selling raises caution about potential risks ahead.Overview: Mobiley","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/march-2025-value-equities-could-110757571.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2242644610.SGD","LU1119994140.HKD","BK4153","LU1863844665.USD","LU2362541513.USD","BK4198","LU1169589451.USD","BK4211","SGXZ23171101.USD","LU0612318385.USD","LU0550127509.SGD","LU0048578792.EUR","LU0471298694.HKD","SW","IE00BLDYK493.USD","SN","MBLY","LU1920063259.USD","LU2242646235.USD","SG9999004303.SGD","LU2242646821.SGD","LU1169590202.USD","LU2298321311.HKD","BK4157","LU2092937221.SGD","ADI","LU1803068623.USD","BK4123","BK4191","BK4124","LU2360106947.USD","LU1430597077.USD","LU1989763427.SGD","PFS","LU1863844749.USD","LU1892829315.USD","LU2360108059.USD","LU0205193047.USD","LU1989763690.USD","LU0612318971.USD","LU2401740654.USD","LU0053671581.USD","CSTM","HAE","LU0654597011.USD","LU0997587240.USD","LU2380233275.USD","KBR","LU0997586606.USD","BK4195","LU2041044095.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PFS\",params:#limit:5,,,undefined,":[{"date":"2025-07-24","symbol":"PFS","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":0.5,"defaultRemindTime":1753344000000,"name":null,"time":"Pre-Market","dateTimestamp":1753329600000,"actualEps":null},{"date":"2025-05-16","symbol":"PFS","amount":0.24,"announcedDate":"2025-04-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-16","defaultRemindTime":1747402200000,"name":"Provident Financial Services Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-30","payableDate":"2025-05-16","currency":"USD","dateTimestamp":1747368000000,"payDate":"2025-05-30"},{"date":"2025-04-24","symbol":"PFS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":0.47,"defaultRemindTime":1745524800000,"name":null,"time":"Post Market","dateTimestamp":1745467200000,"actualEps":null},{"date":"2025-02-14","symbol":"PFS","amount":0.24,"announcedDate":"2025-01-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-14","defaultRemindTime":1739543400000,"name":"Provident Financial Services Inc","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-28","payableDate":"2025-02-14","currency":"USD","dateTimestamp":1739509200000,"payDate":"2025-02-28"},{"market":"US","date":"2025-01-28","symbol":"PFS","fiscalQuarterEnding":"2024/12","expectedEps":0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1738040400000,"reportTimeType":"post","actualEps":0.37}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PFS\",market:\"US\",,,undefined,":[{"executeDate":"2015-08-12","recordDate":"2015-08-14","paymentDate":"2015-08-28","value":0.16,"currency":"USD"},{"executeDate":"2015-11-10","recordDate":"2015-11-13","paymentDate":"2015-11-27","value":0.17,"currency":"USD"},{"executeDate":"2016-02-10","recordDate":"2016-02-12","paymentDate":"2016-02-26","value":0.17,"currency":"USD"},{"executeDate":"2016-05-11","recordDate":"2016-05-13","paymentDate":"2016-05-31","value":0.18,"currency":"USD"},{"executeDate":"2016-08-11","recordDate":"2016-08-15","paymentDate":"2016-08-31","value":0.18,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PFS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1429,"buy":0.7143,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":7,"updateTime":1750996800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PFS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PFS","date":"2025-07-17","current":16.240459,"percent":0.774659,"low":6.410614,"twenty":8.954399,"median":10.710589,"eighty":16.928687,"high":33.979783,"avg":13.452102,"sd":6.422763,"marketCap":2394996736},"quantilePoints":[{"date":"2020-07-24","current":9.601469,"twenty":13.098537,"median":17.431245,"eighty":19.049774,"marketCap":928212371},{"date":"2020-07-31","current":10.146984,"twenty":13.0648,"median":17.422118,"eighty":19.049774,"marketCap":878647633},{"date":"2020-08-07","current":10.689643,"twenty":13.048711,"median":17.403942,"eighty":19.049774,"marketCap":925637580},{"date":"2020-08-14","current":10.527035,"twenty":13.031177,"median":17.388517,"eighty":19.049774,"marketCap":911556975},{"date":"2020-08-21","current":9.599052,"twenty":13.008395,"median":17.362339,"eighty":19.049774,"marketCap":831201106},{"date":"2020-08-28","current":9.947973,"twenty":12.988694,"median":17.334295,"eighty":19.049774,"marketCap":861414913},{"date":"2020-09-04","current":10.155841,"twenty":12.944965,"median":17.31872,"eighty":19.049774,"marketCap":879414627},{"date":"2020-09-11","current":9.509966,"twenty":12.926046,"median":17.247931,"eighty":19.049774,"marketCap":823486942},{"date":"2020-09-18","current":9.539661,"twenty":12.903594,"median":17.204455,"eighty":19.049774,"marketCap":826058330},{"date":"2020-09-25","current":8.916057,"twenty":12.85637,"median":17.165483,"eighty":19.049774,"marketCap":772059186},{"date":"2020-10-02","current":9.457999,"twenty":12.836682,"median":17.1464,"eighty":19.049774,"marketCap":818987014},{"date":"2020-10-09","current":9.777225,"twenty":12.825762,"median":17.106994,"eighty":19.030829,"marketCap":846629433},{"date":"2020-10-16","current":9.658443,"twenty":12.807943,"median":17.057235,"eighty":18.996004,"marketCap":836343881},{"date":"2020-10-23","current":10.222656,"twenty":12.774984,"median":17.027417,"eighty":18.941136,"marketCap":885200250},{"date":"2020-10-30","current":10.595048,"twenty":12.75677,"median":16.971439,"eighty":18.91343,"marketCap":872343311},{"date":"2020-11-06","current":10.696549,"twenty":12.723452,"median":16.947615,"eighty":18.891695,"marketCap":880700321},{"date":"2020-11-13","current":13.674488,"twenty":12.723452,"median":16.898923,"eighty":18.890505,"marketCap":1125888942},{"date":"2020-11-20","current":14.639195,"twenty":12.723452,"median":16.877422,"eighty":18.890505,"marketCap":1205318094},{"date":"2020-11-27","current":15.191794,"twenty":12.723452,"median":16.856678,"eighty":18.890505,"marketCap":1250816345},{"date":"2020-12-04","current":16.053474,"twenty":12.723452,"median":16.820466,"eighty":18.876273,"marketCap":1321762772},{"date":"2020-12-11","current":16.072206,"twenty":12.723452,"median":16.79439,"eighty":18.876273,"marketCap":1323305085},{"date":"2020-12-18","current":16.222063,"twenty":12.723452,"median":16.774835,"eighty":18.876273,"marketCap":1335643594},{"date":"2020-12-24","current":16.718466,"twenty":12.723452,"median":16.730308,"eighty":18.876273,"marketCap":1376514905},{"date":"2020-12-31","current":16.821493,"twenty":12.723452,"median":16.724895,"eighty":18.876273,"marketCap":1384997630},{"date":"2021-01-08","current":18.095281,"twenty":12.723452,"median":16.724895,"eighty":18.876273,"marketCap":1489874956},{"date":"2021-01-15","current":17.992254,"twenty":12.723452,"median":16.744122,"eighty":18.876273,"marketCap":1481392232},{"date":"2021-01-22","current":18.142111,"twenty":12.723452,"median":16.774835,"eighty":18.876273,"marketCap":1493730740},{"date":"2021-01-29","current":14.720538,"twenty":12.723452,"median":16.78893,"eighty":18.876273,"marketCap":1427170886},{"date":"2021-02-05","current":15.094115,"twenty":12.723452,"median":16.757917,"eighty":18.876273,"marketCap":1463389586},{"date":"2021-02-12","current":15.571023,"twenty":12.723452,"median":16.755695,"eighty":18.876273,"marketCap":1509626224},{"date":"2021-02-19","current":15.626662,"twenty":12.723452,"median":16.724895,"eighty":18.876273,"marketCap":1515020498},{"date":"2021-02-26","current":16.079724,"twenty":12.723452,"median":16.714233,"eighty":18.876273,"marketCap":1558945304},{"date":"2021-03-05","current":17.794179,"twenty":12.721872,"median":16.671636,"eighty":18.877325,"marketCap":1725163471},{"date":"2021-03-12","current":18.789768,"twenty":12.721872,"median":16.671636,"eighty":18.877325,"marketCap":1821686827},{"date":"2021-03-19","current":18.215526,"twenty":12.721872,"median":16.671636,"eighty":18.877325,"marketCap":1766013442},{"date":"2021-03-26","current":18.002063,"twenty":12.723452,"median":16.674486,"eighty":18.876273,"marketCap":1745317972},{"date":"2021-04-01","current":17.749069,"twenty":12.723452,"median":16.674486,"eighty":18.876273,"marketCap":1720790008},{"date":"2021-04-09","current":18.24715,"twenty":12.721872,"median":16.671636,"eighty":18.877325,"marketCap":1769079438},{"date":"2021-04-16","current":18.405271,"twenty":12.721872,"median":16.671636,"eighty":18.877325,"marketCap":1784409415},{"date":"2021-04-23","current":18.674076,"twenty":12.721872,"median":16.671636,"eighty":18.877325,"marketCap":1810470378},{"date":"2021-04-30","current":14.042944,"twenty":12.721872,"median":16.669814,"eighty":18.884491,"marketCap":1833713567},{"date":"2021-05-07","current":15.049841,"twenty":12.721872,"median":16.625436,"eighty":18.884491,"marketCap":1965193242},{"date":"2021-05-14","current":15.169001,"twenty":12.721872,"median":16.591954,"eighty":18.884491,"marketCap":1980752967},{"date":"2021-05-21","current":15.133253,"twenty":12.721872,"median":16.545238,"eighty":18.884491,"marketCap":1976085049},{"date":"2021-05-28","current":15.049841,"twenty":12.721872,"median":16.529666,"eighty":18.884491,"marketCap":1965193242},{"date":"2021-06-04","current":15.043883,"twenty":12.721872,"median":16.506308,"eighty":18.884491,"marketCap":1964415256},{"date":"2021-06-11","current":14.722153,"twenty":12.721872,"median":16.44402,"eighty":18.884491,"marketCap":1922403999},{"date":"2021-06-18","current":13.679507,"twenty":12.721872,"median":16.40509,"eighty":18.884491,"marketCap":1786256407},{"date":"2021-06-25","current":14.227641,"twenty":12.721872,"median":16.3245,"eighty":18.884491,"marketCap":1857831141},{"date":"2021-07-02","current":13.500768,"twenty":12.721872,"median":16.302281,"eighty":18.884491,"marketCap":1762916819},{"date":"2021-07-09","current":13.244575,"twenty":12.721872,"median":16.261288,"eighty":18.884491,"marketCap":1729463411},{"date":"2021-07-16","current":12.976467,"twenty":12.721872,"median":16.250162,"eighty":18.884491,"marketCap":1694454030},{"date":"2021-07-23","current":12.55345,"twenty":12.69964,"median":16.222063,"eighty":18.884491,"marketCap":1639217007},{"date":"2021-07-30","current":10.433885,"twenty":12.684833,"median":16.184117,"eighty":18.884491,"marketCap":1680450278},{"date":"2021-08-06","current":10.849309,"twenty":12.675728,"median":16.148152,"eighty":18.884491,"marketCap":1747357095},{"date":"2021-08-13","current":10.552042,"twenty":12.660863,"median":16.109223,"eighty":18.884491,"marketCap":1699480276},{"date":"2021-08-20","current":10.381313,"twenty":12.614911,"median":16.079724,"eighty":18.884491,"marketCap":1671983067},{"date":"2021-08-27","current":10.571012,"twenty":12.560516,"median":16.051403,"eighty":18.884491,"marketCap":1702535521},{"date":"2021-09-03","current":10.362343,"twenty":12.528973,"median":16.012247,"eighty":18.884491,"marketCap":1668927821},{"date":"2021-09-10","current":10.43348,"twenty":12.478039,"median":15.976834,"eighty":18.884491,"marketCap":1680384992},{"date":"2021-09-17","current":10.542557,"twenty":12.463634,"median":15.915973,"eighty":18.884491,"marketCap":1697952653},{"date":"2021-09-24","current":10.841334,"twenty":12.367008,"median":15.852207,"eighty":18.884491,"marketCap":1746072768},{"date":"2021-10-01","current":11.315583,"twenty":12.317066,"median":15.827979,"eighty":18.884491,"marketCap":1822453904},{"date":"2021-10-08","current":11.718695,"twenty":12.271397,"median":15.788905,"eighty":18.884491,"marketCap":1887377870},{"date":"2021-10-15","current":11.713953,"twenty":12.250326,"median":15.716295,"eighty":18.884491,"marketCap":1886614059},{"date":"2021-10-22","current":11.808802,"twenty":12.188782,"median":15.680935,"eighty":18.884491,"marketCap":1901890286},{"date":"2021-10-29","current":11.169949,"twenty":12.144658,"median":15.649322,"eighty":18.884491,"marketCap":1912127768},{"date":"2021-11-05","current":11.584988,"twenty":12.022084,"median":15.636232,"eighty":18.884491,"marketCap":1983176134},{"date":"2021-11-12","current":11.413559,"twenty":11.87183,"median":15.555472,"eighty":18.877325,"marketCap":1953830070},{"date":"2021-11-19","current":11.06619,"twenty":11.803248,"median":15.475641,"eighty":18.822017,"marketCap":1894365677},{"date":"2021-11-26","current":10.935362,"twenty":11.752841,"median":15.361209,"eighty":18.799671,"marketCap":1871969996},{"date":"2021-12-03","current":10.660174,"twenty":11.700674,"median":15.25837,"eighty":18.766081,"marketCap":1824861840},{"date":"2021-12-10","current":10.64664,"twenty":11.597269,"median":15.189807,"eighty":18.713257,"marketCap":1822545046},{"date":"2021-12-17","current":10.745888,"twenty":11.515514,"median":15.166494,"eighty":18.654746,"marketCap":1839534872},{"date":"2021-12-23","current":10.957919,"twenty":11.442431,"median":15.126556,"eighty":18.639247,"marketCap":1875831320},{"date":"2021-12-31","current":10.92634,"twenty":11.368446,"median":15.085589,"eighty":18.621596,"marketCap":1870425466},{"date":"2022-01-07","current":11.738372,"twenty":11.326022,"median":15.058778,"eighty":18.579091,"marketCap":2009433139},{"date":"2022-01-14","current":11.729349,"twenty":11.326022,"median":15.040904,"eighty":18.531427,"marketCap":2007888610},{"date":"2022-01-21","current":10.863182,"twenty":11.299875,"median":15.028989,"eighty":18.489553,"marketCap":1859613758},{"date":"2022-01-28","current":11.023748,"twenty":11.261979,"median":15.001772,"eighty":18.453467,"marketCap":1851118845},{"date":"2022-02-04","current":11.088134,"twenty":11.181448,"median":14.930112,"eighty":18.423167,"marketCap":1861930553},{"date":"2022-02-11","current":10.92717,"twenty":11.115728,"median":14.912327,"eighty":18.41438,"marketCap":1834901283},{"date":"2022-02-18","current":10.92717,"twenty":11.065654,"median":14.87528,"eighty":18.386528,"marketCap":1834901283},{"date":"2022-02-25","current":10.732094,"twenty":11.023748,"median":14.820597,"eighty":18.371521,"marketCap":1802143926},{"date":"2022-03-04","current":10.629654,"twenty":11.007105,"median":14.772796,"eighty":18.349914,"marketCap":1784942161},{"date":"2022-03-11","current":10.652348,"twenty":10.957288,"median":14.734826,"eighty":18.315942,"marketCap":1788752883},{"date":"2022-03-18","current":10.806664,"twenty":10.92634,"median":14.709739,"eighty":18.308123,"marketCap":1814665792},{"date":"2022-03-25","current":10.720428,"twenty":10.866543,"median":14.669048,"eighty":18.291682,"marketCap":1800185049},{"date":"2022-04-01","current":10.629654,"twenty":10.847714,"median":14.635382,"eighty":18.253335,"marketCap":1784942161},{"date":"2022-04-08","current":10.053238,"twenty":10.819838,"median":14.583758,"eighty":18.229989,"marketCap":1688149823},{"date":"2022-04-14","current":10.071393,"twenty":10.805336,"median":14.512906,"eighty":18.210171,"marketCap":1691198401},{"date":"2022-04-22","current":10.171245,"twenty":10.764,"median":14.497563,"eighty":18.192392,"marketCap":1707965577},{"date":"2022-04-29","current":10.150722,"twenty":10.733654,"median":14.451873,"eighty":18.177577,"marketCap":1657856535},{"date":"2022-05-06","current":10.297502,"twenty":10.713769,"median":14.383195,"eighty":18.14275,"marketCap":1681829155},{"date":"2022-05-13","current":9.954658,"twenty":10.67461,"median":14.304676,"eighty":18.117189,"marketCap":1625834598},{"date":"2022-05-20","current":10.078233,"twenty":10.650249,"median":14.249341,"eighty":18.096905,"marketCap":1646017372},{"date":"2022-05-27","current":10.572534,"twenty":10.629654,"median":14.193648,"eighty":18.064002,"marketCap":1726748469},{"date":"2022-06-03","current":10.412344,"twenty":10.620376,"median":14.117725,"eighty":18.057139,"marketCap":1700585614},{"date":"2022-06-10","current":10.000427,"twenty":10.605236,"median":13.994542,"eighty":18.016495,"marketCap":1633309699},{"date":"2022-06-17","current":9.92262,"twenty":10.570637,"median":13.872371,"eighty":17.998745,"marketCap":1620602026},{"date":"2022-06-24","current":10.165194,"twenty":10.552314,"median":13.685465,"eighty":17.991294,"marketCap":1660220065},{"date":"2022-07-01","current":10.513034,"twenty":10.530137,"median":13.611721,"eighty":17.968495,"marketCap":1717030837},{"date":"2022-07-08","current":10.31623,"twenty":10.524934,"median":13.456373,"eighty":17.95339,"marketCap":1684887900},{"date":"2022-07-15","current":10.288769,"twenty":10.512341,"median":13.392091,"eighty":17.910649,"marketCap":1680402839},{"date":"2022-07-22","current":10.613725,"twenty":10.505887,"median":13.327225,"eighty":17.849237,"marketCap":1733476061},{"date":"2022-07-29","current":11.467199,"twenty":10.505887,"median":13.302306,"eighty":17.813962,"marketCap":1809111112},{"date":"2022-08-05","current":11.377758,"twenty":10.505887,"median":13.239282,"eighty":17.786291,"marketCap":1795000639},{"date":"2022-08-12","current":11.739288,"twenty":10.505887,"median":13.221695,"eighty":17.762714,"marketCap":1852037025},{"date":"2022-08-19","current":11.748717,"twenty":10.505887,"median":13.209959,"eighty":17.748875,"marketCap":1853524605},{"date":"2022-08-26","current":11.296118,"twenty":10.505887,"median":13.188531,"eighty":17.733901,"marketCap":1782120768},{"date":"2022-09-02","current":10.848234,"twenty":10.505887,"median":13.150076,"eighty":17.684237,"marketCap":1711460720},{"date":"2022-09-09","current":10.928381,"twenty":10.505887,"median":13.130958,"eighty":17.66138,"marketCap":1724105150},{"date":"2022-09-16","current":11.036817,"twenty":10.505887,"median":13.113536,"eighty":17.644475,"marketCap":1741212319},{"date":"2022-09-23","current":10.980242,"twenty":10.505887,"median":13.081395,"eighty":17.623016,"marketCap":1732286840},{"date":"2022-09-30","current":9.193418,"twenty":10.478391,"median":13.065324,"eighty":17.59628,"marketCap":1450390441},{"date":"2022-10-07","current":9.075554,"twenty":10.469523,"median":13.052449,"eighty":17.561143,"marketCap":1431795692},{"date":"2022-10-14","current":9.580013,"twenty":10.437974,"median":13.034632,"eighty":17.546569,"marketCap":1511381219},{"date":"2022-10-21","current":9.716736,"twenty":10.425892,"median":13.011756,"eighty":17.514492,"marketCap":1532951128},{"date":"2022-10-28","current":10.271339,"twenty":10.389888,"median":12.992653,"eighty":17.479985,"marketCap":1683636796},{"date":"2022-11-04","current":10.266754,"twenty":10.377223,"median":12.955005,"eighty":17.444428,"marketCap":1682885173},{"date":"2022-11-11","current":10.291061,"twenty":10.357421,"median":12.934931,"eighty":17.408903,"marketCap":1686869566},{"date":"2022-11-18","current":10.064186,"twenty":10.320716,"median":12.924436,"eighty":17.359105,"marketCap":1649681083},{"date":"2022-11-25","current":10.272911,"twenty":10.310098,"median":12.883192,"eighty":17.323674,"marketCap":1683894487},{"date":"2022-12-02","current":10.204848,"twenty":10.293993,"median":12.857307,"eighty":17.216387,"marketCap":1672737942},{"date":"2022-12-09","current":9.973436,"twenty":10.282719,"median":12.842174,"eighty":17.162345,"marketCap":1634805690},{"date":"2022-12-16","current":9.360873,"twenty":10.269156,"median":12.829982,"eighty":17.036971,"marketCap":1534396787},{"date":"2022-12-23","current":9.719335,"twenty":10.253097,"median":12.811402,"eighty":16.964208,"marketCap":1593154590},{"date":"2022-12-30","current":9.69211,"twenty":10.230259,"median":12.79325,"eighty":16.866633,"marketCap":1588691972},{"date":"2023-01-06","current":9.896298,"twenty":10.216454,"median":12.770698,"eighty":16.761899,"marketCap":1622161606},{"date":"2023-01-13","current":10.150398,"twenty":10.193425,"median":12.743914,"eighty":16.690368,"marketCap":1663812707},{"date":"2023-01-20","current":10.213923,"twenty":10.187062,"median":12.725033,"eighty":16.523587,"marketCap":1674225482},{"date":"2023-01-27","current":9.790009,"twenty":10.173843,"median":12.690346,"eighty":16.324736,"marketCap":1719595430},{"date":"2023-02-03","current":10.396723,"twenty":10.16752,"median":12.677807,"eighty":16.256402,"marketCap":1826163591},{"date":"2023-02-10","current":10.238158,"twenty":10.16752,"median":12.667312,"eighty":16.23143,"marketCap":1798311961},{"date":"2023-02-17","current":10.259586,"twenty":10.15802,"median":12.637027,"eighty":16.127135,"marketCap":1802075695},{"date":"2023-02-24","current":10.011024,"twenty":10.149032,"median":12.580612,"eighty":16.062409,"marketCap":1758416384},{"date":"2023-03-03","current":9.946656,"twenty":10.12732,"median":12.54984,"eighty":16.029311,"marketCap":1747110222},{"date":"2023-03-10","current":8.806492,"twenty":10.110262,"median":12.491259,"eighty":15.99002,"marketCap":1546842669},{"date":"2023-03-17","current":8.551231,"twenty":10.087476,"median":12.467781,"eighty":15.924154,"marketCap":1502006690},{"date":"2023-03-24","current":8.308734,"twenty":10.075497,"median":12.378703,"eighty":15.861307,"marketCap":1459412470},{"date":"2023-03-31","current":8.159832,"twenty":10.060803,"median":12.352386,"eighty":15.839714,"marketCap":1433258125},{"date":"2023-04-06","current":7.704617,"twenty":10.04356,"median":12.287536,"eighty":15.796939,"marketCap":1353300555},{"date":"2023-04-14","current":7.832247,"twenty":10.027135,"median":12.261119,"eighty":15.730693,"marketCap":1375718565},{"date":"2023-04-21","current":7.74716,"twenty":10.017452,"median":12.211348,"eighty":15.694,"marketCap":1360773225},{"date":"2023-04-28","current":7.593207,"twenty":9.999766,"median":12.160062,"eighty":15.664957,"marketCap":1307717267},{"date":"2023-05-05","current":6.573548,"twenty":9.989771,"median":12.09154,"eighty":15.642667,"marketCap":1132109520},{"date":"2023-05-12","current":6.495446,"twenty":9.971621,"median":11.987273,"eighty":15.600987,"marketCap":1118658713},{"date":"2023-05-19","current":7.029498,"twenty":9.961387,"median":11.888242,"eighty":15.530275,"marketCap":1210634281},{"date":"2023-05-26","current":7.046909,"twenty":9.952827,"median":11.808802,"eighty":15.39865,"marketCap":1213632756},{"date":"2023-06-02","current":7.116551,"twenty":9.943684,"median":11.780347,"eighty":15.324881,"marketCap":1225626656},{"date":"2023-06-09","current":7.90873,"twenty":9.929925,"median":11.738372,"eighty":15.203096,"marketCap":1362057268},{"date":"2023-06-16","current":7.934846,"twenty":9.905841,"median":11.713953,"eighty":15.174007,"marketCap":1366554981},{"date":"2023-06-23","current":7.221014,"twenty":9.886325,"median":11.649929,"eighty":15.134319,"marketCap":1243617506},{"date":"2023-06-30","current":7.260188,"twenty":9.866996,"median":11.584988,"eighty":15.109317,"marketCap":1250364075},{"date":"2023-07-07","current":6.946798,"twenty":9.848756,"median":11.548897,"eighty":15.068412,"marketCap":1196391525},{"date":"2023-07-14","current":7.499583,"twenty":9.820363,"median":11.505283,"eighty":15.049841,"marketCap":1291593106},{"date":"2023-07-21","current":8.108951,"twenty":9.78572,"median":11.467199,"eighty":15.032889,"marketCap":1396539731},{"date":"2023-07-28","current":8.682159,"twenty":9.742349,"median":11.428126,"eighty":15.003286,"marketCap":1432521431},{"date":"2023-08-04","current":8.409258,"twenty":9.731294,"median":11.387173,"eighty":14.9415,"marketCap":1387493907},{"date":"2023-08-11","current":8.120111,"twenty":9.718285,"median":11.354912,"eighty":14.916422,"marketCap":1339785831},{"date":"2023-08-18","current":7.624539,"twenty":9.704927,"median":11.300777,"eighty":14.879018,"marketCap":1258018387},{"date":"2023-08-25","current":7.506329,"twenty":9.663774,"median":11.282731,"eighty":14.826043,"marketCap":1238514226},{"date":"2023-09-01","current":7.492689,"twenty":9.624389,"median":11.244446,"eighty":14.781733,"marketCap":1236263745},{"date":"2023-09-08","current":7.310828,"twenty":9.599052,"median":11.197237,"eighty":14.751943,"marketCap":1206257344},{"date":"2023-09-15","current":7.388119,"twenty":9.572255,"median":11.168825,"eighty":14.716388,"marketCap":1219010065},{"date":"2023-09-22","current":6.997117,"twenty":9.538302,"median":11.11225,"eighty":14.678775,"marketCap":1154496301},{"date":"2023-09-29","current":6.951652,"twenty":9.501581,"median":11.06619,"eighty":14.644899,"marketCap":1146994701},{"date":"2023-10-06","current":6.951652,"twenty":9.471361,"median":11.046743,"eighty":14.595078,"marketCap":1146994701},{"date":"2023-10-13","current":6.792523,"twenty":9.431033,"median":11.012054,"eighty":14.515019,"marketCap":1120739099},{"date":"2023-10-20","current":6.542463,"twenty":9.372419,"median":10.980475,"eighty":14.499896,"marketCap":1079480297},{"date":"2023-10-27","current":7.170747,"twenty":9.358917,"median":10.957919,"eighty":14.471655,"marketCap":1076479657},{"date":"2023-11-03","current":7.537213,"twenty":9.227549,"median":10.936586,"eighty":14.399708,"marketCap":1131493992},{"date":"2023-11-10","current":7.179977,"twenty":9.151165,"median":10.92634,"eighty":14.31961,"marketCap":1077865333},{"date":"2023-11-17","current":7.734589,"twenty":9.108811,"median":10.883634,"eighty":14.267749,"marketCap":1161124242},{"date":"2023-11-24","current":7.594687,"twenty":9.078197,"median":10.857,"eighty":14.214839,"marketCap":1140121995},{"date":"2023-12-01","current":7.60468,"twenty":8.976162,"median":10.840069,"eighty":14.143037,"marketCap":1141622155},{"date":"2023-12-08","current":8.214253,"twenty":8.928966,"median":10.82028,"eighty":14.03685,"marketCap":1233131947},{"date":"2023-12-15","current":9.103631,"twenty":8.896863,"median":10.805953,"eighty":13.930523,"marketCap":1366646233},{"date":"2023-12-22","current":9.083645,"twenty":8.896863,"median":10.78687,"eighty":13.759594,"marketCap":1363645912},{"date":"2023-12-29","current":9.223547,"twenty":8.892939,"median":10.761277,"eighty":13.668342,"marketCap":1384648159},{"date":"2024-01-05","current":8.743883,"twenty":8.862382,"median":10.745888,"eighty":13.56351,"marketCap":1312640455},{"date":"2024-01-12","current":8.583995,"twenty":8.806492,"median":10.720428,"eighty":13.408162,"marketCap":1288637886},{"date":"2024-01-19","current":8.309187,"twenty":8.772881,"median":10.697142,"eighty":13.342249,"marketCap":1247383472},{"date":"2024-01-26","current":8.828824,"twenty":8.752732,"median":10.656886,"eighty":13.316627,"marketCap":1325391819},{"date":"2024-02-02","current":9.490046,"twenty":8.752732,"median":10.64215,"eighty":13.30073,"marketCap":1218502920},{"date":"2024-02-09","current":8.830529,"twenty":8.752732,"median":10.629654,"eighty":13.236743,"marketCap":1133822213},{"date":"2024-02-16","current":9.326626,"twenty":8.752732,"median":10.620577,"eighty":13.221244,"marketCap":1197520090},{"date":"2024-02-23","current":8.865547,"twenty":8.752732,"median":10.61055,"eighty":13.209959,"marketCap":1138318534},{"date":"2024-03-01","current":8.801346,"twenty":8.74965,"median":10.589265,"eighty":13.19135,"marketCap":1130075279},{"date":"2024-03-08","current":8.986315,"twenty":8.743883,"median":10.567288,"eighty":13.154274,"marketCap":1153824926},{"date":"2024-03-15","current":8.329352,"twenty":8.723902,"median":10.538449,"eighty":13.128485,"marketCap":1069472190},{"date":"2024-03-22","current":8.96157,"twenty":8.698898,"median":10.5269,"eighty":13.112465,"marketCap":1150647615},{"date":"2024-03-28","current":8.466976,"twenty":8.693607,"median":10.517516,"eighty":13.098537,"marketCap":1087142753},{"date":"2024-04-05","current":8.466976,"twenty":8.653336,"median":10.488954,"eighty":13.065324,"marketCap":1087142753},{"date":"2024-04-12","current":7.990046,"twenty":8.61897,"median":10.476162,"eighty":13.052449,"marketCap":1025905922},{"date":"2024-04-19","current":8.671317,"twenty":8.578848,"median":10.466677,"eighty":13.034632,"marketCap":1040072426},{"date":"2024-04-26","current":9.585747,"twenty":8.579877,"median":10.437517,"eighty":13.020302,"marketCap":1149752791},{"date":"2024-05-03","current":9.605463,"twenty":8.579877,"median":10.431596,"eighty":12.999364,"marketCap":1152117669},{"date":"2024-05-10","current":10.091416,"twenty":8.579877,"median":10.40199,"eighty":12.962642,"marketCap":1210404831},{"date":"2024-05-17","current":10.167149,"twenty":8.579877,"median":10.387579,"eighty":12.944965,"marketCap":1219488545},{"date":"2024-05-24","current":9.554974,"twenty":8.579877,"median":10.368229,"eighty":12.926046,"marketCap":1146061860},{"date":"2024-05-31","current":15.595237,"twenty":8.579877,"median":10.368229,"eighty":12.928956,"marketCap":1870555147},{"date":"2024-06-07","current":14.804645,"twenty":8.579877,"median":10.368229,"eighty":12.944965,"marketCap":1775728393},{"date":"2024-06-14","current":14.479745,"twenty":8.579877,"median":10.368229,"eighty":12.974084,"marketCap":1736758494},{"date":"2024-06-21","current":14.609705,"twenty":8.578848,"median":10.365511,"eighty":13.001042,"marketCap":1752346453},{"date":"2024-06-28","current":15.541087,"twenty":8.578848,"median":10.365511,"eighty":13.028149,"marketCap":1864060164},{"date":"2024-07-05","current":15.400297,"twenty":8.578848,"median":10.365511,"eighty":13.034632,"marketCap":1847173207},{"date":"2024-07-12","current":17.403852,"twenty":8.578848,"median":10.365511,"eighty":13.034632,"marketCap":2087487584},{"date":"2024-07-19","current":19.212466,"twenty":8.578848,"median":10.365511,"eighty":13.039572,"marketCap":2304420021},{"date":"2024-07-26","current":32.346496,"twenty":8.578848,"median":10.365511,"eighty":13.039572,"marketCap":2473083727},{"date":"2024-08-02","current":29.436843,"twenty":8.578848,"median":10.365511,"eighty":13.071794,"marketCap":2250623276},{"date":"2024-08-09","current":28.842709,"twenty":8.578848,"median":10.365511,"eighty":13.113823,"marketCap":2205198173},{"date":"2024-08-16","current":30.822445,"twenty":8.578848,"median":10.365511,"eighty":13.134508,"marketCap":2356560887},{"date":"2024-08-23","current":32.631515,"twenty":8.578848,"median":10.365511,"eighty":13.176313,"marketCap":2494875092},{"date":"2024-08-30","current":32.546181,"twenty":8.578848,"median":10.365511,"eighty":13.215944,"marketCap":2488350837},{"date":"2024-09-06","current":31.197913,"twenty":8.578848,"median":10.365511,"eighty":13.228055,"marketCap":2385267609},{"date":"2024-09-13","current":31.300313,"twenty":8.578848,"median":10.365511,"eighty":13.30073,"marketCap":2393096715},{"date":"2024-09-20","current":32.187781,"twenty":8.578848,"median":10.365511,"eighty":13.316627,"marketCap":2460948967},{"date":"2024-09-27","current":31.283246,"twenty":8.578848,"median":10.365511,"eighty":13.405115,"marketCap":2391791864},{"date":"2024-10-04","current":30.429912,"twenty":8.578848,"median":10.365511,"eighty":13.64376,"marketCap":2326549315},{"date":"2024-10-11","current":32.136581,"twenty":8.578848,"median":10.365511,"eighty":13.888037,"marketCap":2457034414},{"date":"2024-10-18","current":33.314182,"twenty":8.578848,"median":10.365511,"eighty":14.144229,"marketCap":2547069132},{"date":"2024-10-25","current":31.88058,"twenty":8.578848,"median":10.365511,"eighty":14.323115,"marketCap":2437461649},{"date":"2024-11-01","current":26.079311,"twenty":8.578848,"median":10.365511,"eighty":14.468915,"marketCap":2459644116},{"date":"2024-11-08","current":29.303632,"twenty":8.578848,"median":10.365511,"eighty":14.501405,"marketCap":2763742765},{"date":"2024-11-15","current":29.608014,"twenty":8.578848,"median":10.365511,"eighty":14.577215,"marketCap":2792450197},{"date":"2024-11-22","current":29.608014,"twenty":8.578848,"median":10.365511,"eighty":14.642195,"marketCap":2792450197},{"date":"2024-11-29","current":29.220619,"twenty":8.578848,"median":10.365511,"eighty":14.720538,"marketCap":2755913466},{"date":"2024-12-06","current":28.72254,"twenty":8.578848,"median":10.365511,"eighty":14.772155,"marketCap":2708937668},{"date":"2024-12-13","current":28.16912,"twenty":8.578848,"median":10.365511,"eighty":14.811522,"marketCap":2656742337},{"date":"2024-12-20","current":26.370502,"twenty":8.578848,"median":10.365511,"eighty":14.879507,"marketCap":2487107512},{"date":"2024-12-27","current":26.107627,"twenty":8.578848,"median":10.365511,"eighty":14.930682,"marketCap":2462314730},{"date":"2025-01-03","current":26.19064,"twenty":8.578848,"median":10.365511,"eighty":15.008136,"marketCap":2470144030},{"date":"2025-01-10","current":24.945443,"twenty":8.578722,"median":10.36461,"eighty":15.045075,"marketCap":2352704535},{"date":"2025-01-17","current":26.730225,"twenty":8.578722,"median":10.36461,"eighty":15.087294,"marketCap":2521034477},{"date":"2025-01-24","current":26.232147,"twenty":8.578722,"median":10.36461,"eighty":15.170193,"marketCap":2474058679},{"date":"2025-01-31","current":20.975271,"twenty":8.578722,"median":10.36461,"eighty":15.27162,"marketCap":2423168232},{"date":"2025-02-07","current":21.686872,"twenty":8.578722,"median":10.36461,"eighty":15.43113,"marketCap":2505375878},{"date":"2025-02-14","current":21.065633,"twenty":8.578722,"median":10.36461,"eighty":15.506431,"marketCap":2433607298},{"date":"2025-02-21","current":20.489576,"twenty":8.578722,"median":10.36461,"eighty":15.601522,"marketCap":2367058251},{"date":"2025-02-28","current":20.614008,"twenty":8.578722,"median":10.36461,"eighty":15.733365,"marketCap":2381433247},{"date":"2025-03-07","current":19.427996,"twenty":8.578596,"median":10.36371,"eighty":15.909803,"marketCap":2244419279},{"date":"2025-03-14","current":19.373214,"twenty":8.58723,"median":10.384564,"eighty":16.110435,"marketCap":2238090520},{"date":"2025-03-21","current":19.113398,"twenty":8.626133,"median":10.390798,"eighty":16.250162,"marketCap":2208075312},{"date":"2025-03-28","current":19.282843,"twenty":8.679674,"median":10.422436,"eighty":16.324736,"marketCap":2227650448},{"date":"2025-04-04","current":17.498022,"twenty":8.697705,"median":10.433885,"eighty":16.538637,"marketCap":2021459018},{"date":"2025-04-11","current":16.594315,"twenty":8.729831,"median":10.450581,"eighty":16.720339,"marketCap":1917058294},{"date":"2025-04-17","current":17.498022,"twenty":8.74788,"median":10.472646,"eighty":16.838352,"marketCap":2021459018},{"date":"2025-04-25","current":14.654875,"twenty":8.784492,"median":10.48224,"eighty":16.926427,"marketCap":2161169063},{"date":"2025-05-02","current":15.142189,"twenty":8.798752,"median":10.513034,"eighty":16.926427,"marketCap":2233033814},{"date":"2025-05-09","current":15.159534,"twenty":8.804878,"median":10.526765,"eighty":16.926427,"marketCap":2235591607},{"date":"2025-05-16","current":15.505075,"twenty":8.82909,"median":10.533858,"eighty":16.926427,"marketCap":2286548985},{"date":"2025-05-23","current":14.787412,"twenty":8.855843,"median":10.556785,"eighty":16.926427,"marketCap":2180714431},{"date":"2025-05-30","current":14.884872,"twenty":8.8606,"median":10.572534,"eighty":16.926427,"marketCap":2195087025},{"date":"2025-06-06","current":14.619071,"twenty":8.875633,"median":10.60779,"eighty":16.926427,"marketCap":2155889043},{"date":"2025-06-13","current":15.000053,"twenty":8.887975,"median":10.619572,"eighty":16.926427,"marketCap":2212072818},{"date":"2025-06-20","current":14.30011,"twenty":8.911603,"median":10.626285,"eighty":16.928687,"marketCap":2108851463},{"date":"2025-06-27","current":15.850617,"twenty":8.946056,"median":10.641658,"eighty":16.928687,"marketCap":2337506362},{"date":"2025-07-03","current":16.710041,"twenty":8.946056,"median":10.65175,"eighty":16.928687,"marketCap":2464246506},{"date":"2025-07-11","current":16.648021,"twenty":8.954399,"median":10.683931,"eighty":16.928687,"marketCap":2455100310},{"date":"2025-07-17","current":16.240459,"twenty":8.954399,"median":10.710589,"eighty":16.928687,"marketCap":2394996736}],"updateTime":1752855394982}}}